PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Home Skinovations Ltd.

USPTO PatentsView assignee record - 12 granted patents across 5 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Home ranks #22,720 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 5 technology areas.

#22,720
of 49,997 US assignees by volume
6th percentile
by Innovation Score (19.9/100)
5.2
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22720 · Foreign Corporation #22,720 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 12 grants
  • MID-PACK #22,720/49,997
  • PHOTO-FINISH High Performance…
  • CPC-NARROW A61N · 5 areas
  • INNOV-LOW 19.9/100
  • CLAIMS-SPARSE 5.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: High Performance Optics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Home’s 19.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Home

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Home's Innovation Score is 19.9/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Home?

Each dot is one of Home’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Home’s own 5.2 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Home vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 11.911.91212.1 010203040 Granted patents (volume) Avg claims / patent High Performance Optics, Inc. - 12, 21.83High Performance…HighRadius Corporation - 12, 18.83HighradiusHitachi Transport System, Ltd. - 12, 10.17Hitachi Transport…Hologram Holdings I, Inc. - 12, 1Hologram Holdings…HomeWAV, LLC - 12, 29.58HomewavHopin Ltd - 12, 13.5HopinHough Ear Institute - 12, 17.58Hough Ear Institu…Hughey & Phillips, LLC - 12, 18.75Hughey & PhillipsHome Skinovations Ltd. - 12, 5.17Home Skinovations
Home vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Home's grants concentrate

Home Skinovations Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 25% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2015. By volume, Home sits between High Performance Optics, Inc. and Hughey & Phillips, LLC.

Who files at Home's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Home holds 12 patents at rank #22,727, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Home

By rank, the assignees closest to #22,727 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Home's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Home, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Home ranks #941 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (20 here).

Khoury Medical Devices, LLC 20 MSD Consumer Care, Inc. 20 Humancentric Ventures LLC 20 Dongguan Yuanchuang Electronic Technology Co., Ltd. 20

Home's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

20 6th percentile higher than 6% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 20152016201720182019 4
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Home Skinovations Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 8.3%
2016 2 16.7%
2017 4 33.3%
2018 1 8.3%
2019 4 33.3%

Which technologies does Home Skinovations Ltd. patent most?

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Home Skinovations Ltd.'s patent record in context - here's where to go next.

  • Home Skinovations Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 25% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #22,720 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Home Skinovations Ltd. against High Performance Optics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 19.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.